A USC SARS-COV-2 vaccine project and animal paratuberculosis mycobacteria research, winners of the II International Zendal Awards

The project carried out by the Ciqus group on the Sars-COV-2 vaccine has been the awarded in the human health category, while the research on paratuberculosis of the Neiker group has been the awarded…

Biofabri of Zendal Group has been selected by the CEPI as a strategic facility to increase the manufacturing capacity of Covid-19 vaccines at an international scale

The agreement signed between Biofabri of Zendal Group and the CEPI lays down that the biopharmaceutical company will reserve a manufacturing capacity of at least 500 million Covid-19 vaccine doses

CZ VACCINES closed 2019 financial year with a 4,3% increase in annual turnover, compared to 2018.

CZ VACCINES closed 2019 financial year with a 4,3% increase in annual turnover,…

CZ Vaccines secures healthy growth in 2019

CZ Vaccines secures healthy growth in 2019

Zendal rewards the GENVIP research group and pays homage to the scientist María Vallet in the first edition of its awards

The Zendal biopharmaceutical group held the first edition of the International…

CZ Vaccines launches new conjunctival vaccine againts brucellosis in cattle

CZ VACCINES added a new vaccine to their range of brucellosis vaccines with the…

Extension of the date for the presentation of the International Zendal Awards

Candidates will have until 10 October to formalise their registration for this…

Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants

First trial of a new live attenuated Mycobacterium tuberculosis vaccine in…